Coherus Oncology CHRS
NASDAQ CHRS
$0.76 +0.01 (+1.13%)
As of: Nov 6, 2026 · 9:48 AM EST

Coherus Oncology (CHRS) Long-Term Debt Issuances (2016 - 2024)

Updated

Coherus Oncology's Long-Term Debt Issuances was $36.98 million in FY2024.

Analysis

Coherus Oncology (CHRS) Long-Term Debt Issuances (2016 - 2024) Analysis & Trends

From FY2013 onward, Coherus Oncology has reported Long-Term Debt Issuances for 6 years.

  • Long-Term Debt Issuances shows a five-year compound annual growth rate of -12.7% (FY2019 to FY2024).
  • The FY2024 figure marks the lowest annual Long-Term Debt Issuances since FY2013.
  • Per Business Quant data, Long-Term Debt Issuances in earlier years was $240.68 million in FY2022 and $222.16 million in FY2020 (+204.5%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,212.57 Bn 1,186.19 Bn 20.46 Bn -
2 Johnson & Johnson 643.91 Bn 563.77 Bn 17.30 Bn -
3 AbbVie 504.08 Bn 472.09 Bn 13.12 Bn 9.98 Bn
4 Merck 356.96 Bn 319.90 Bn 13.19 Bn -
5 Novartis Ag 310.55 Bn 283.79 Bn - -
6 Astrazeneca 283.57 Bn 257.47 Bn 13.26 Bn -
7 Amgen 246.04 Bn 197.70 Bn 7.58 Bn -
8 Gilead Sciences 206.13 Bn 181.24 Bn 6.73 Bn -
9 Pfizer 164.44 Bn 111.80 Bn 12.56 Bn -
10 Coherus Oncology 115.54 Mn -520.60 Mn 10.07 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -141,000.00
Sep 30, 2022 49.49 Mn
Mar 31, 2022 191.19 Mn
Mar 31, 2021 222.20 Mn
Sep 30, 2020 -674,000.00
Jun 30, 2020 222.83 Mn
Sep 30, 2019 -106,000.00
Jun 30, 2019 185,000.00
Mar 31, 2019 72.88 Mn
Mar 31, 2016 100.00 Mn
API Access

Coherus Oncology Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=CHRS&period=max&api_key=YOUR_API_KEY